BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23453867)

  • 21. Iron deficiency in patients with heart failure.
    Fitzsimons S; Doughty RN
    Eur Heart J Cardiovasc Pharmacother; 2015 Jan; 1(1):58-64. PubMed ID: 27533968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical utility of reticulocyte hemoglobin equivalent in patients with heart failure.
    Tahara S; Naito Y; Okuno K; Yasumura S; Horimatsu T; Ohno J; Sunayama I; Matsumoto Y; Manabe E; Masai K; Azuma K; Nishimura K; Min KD; Goda A; Asakura M; Ishihara M
    Sci Rep; 2022 Aug; 12(1):13978. PubMed ID: 35978001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron Deficiency in Heart Failure: An Overview.
    von Haehling S; Ebner N; Evertz R; Ponikowski P; Anker SD
    JACC Heart Fail; 2019 Jan; 7(1):36-46. PubMed ID: 30553903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re-defining iron deficiency in patients with heart failure.
    Cuthbert JJ; Ransome N; Clark AL
    Expert Rev Cardiovasc Ther; 2022 Aug; 20(8):667-681. PubMed ID: 35815543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Should we use ferritin in the diagnostic criteria of iron deficiency in heart failure patients?
    Gentil JRS; Fabricio CG; Tanaka DM; Suen VMM; Volpe GJ; Marchini JS; Simões MV
    Clin Nutr ESPEN; 2020 Oct; 39():119-123. PubMed ID: 32859304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of Oral Ferric Citrate in Patients With Iron-Deficiency Anemia and Chronic Kidney Disease With or Without Heart Failure.
    McCullough PA; Uhlig K; Neylan JF; Pergola PE; Fishbane S
    Am J Cardiol; 2018 Aug; 122(4):683-688. PubMed ID: 29961562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron deficiency and its management in patients undergoing lipoprotein apheresis. Comparison of two parenteral iron formulations.
    Schatz U; Arneth B; Siegert G; Siegels D; Fischer S; Julius U; Bornstein SR
    Atheroscler Suppl; 2013 Jan; 14(1):115-22. PubMed ID: 23357152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anaemia, iron deficiency and heart failure in 2020: facts and numbers.
    Chopra VK; Anker SD
    ESC Heart Fail; 2020 Oct; 7(5):2007-2011. PubMed ID: 32602663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron deficiency and red cell indices in patients with heart failure.
    Tkaczyszyn M; Comín-Colet J; Voors AA; van Veldhuisen DJ; Enjuanes C; Moliner-Borja P; Rozentryt P; Poloński L; Banasiak W; Ponikowski P; van der Meer P; Jankowska EA
    Eur J Heart Fail; 2018 Jan; 20(1):114-122. PubMed ID: 28386910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Applicability of new proposed criteria for iron deficiency in Japanese patients with heart failure.
    Tada A; Nagai T; Koya T; Nakao M; Ishizaka S; Mizuguchi Y; Aoyagi H; Imagawa S; Tokuda Y; Takahashi M; Kato Y; Machida M; Matsutani K; Saito T; Anzai T;
    ESC Heart Fail; 2023 Apr; 10(2):985-994. PubMed ID: 36495060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is Correction of Iron Deficiency a New Addition to the Treatment of the Heart Failure?
    Silverberg DS; Wexler D; Schwartz D
    Int J Mol Sci; 2015 Jun; 16(6):14056-74. PubMed ID: 26096008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of intravenous iron in patients with iron deficiency and chronic heart failure: Real-world evidence.
    Gonzalez-Costello J; Cainzos-Achirica M; Lupón J; Farré N; Moliner-Borja P; Enjuanes C; de Antonio M; Fuentes L; Díez-López C; Bayés-Genis A; Manito N; Pujol R; Comin-Colet J
    Eur J Intern Med; 2020 Oct; 80():91-98. PubMed ID: 32439287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute heart failure and iron deficiency: a prospective, multicentre, observational study.
    van Dalen DH; Kragten JA; Emans ME; van Ofwegen-Hanekamp CEE; Klaarwater CCR; Spanjers MHA; Hendrick R; van Deursen CTBM; Brunner-La Rocca HP
    ESC Heart Fail; 2022 Feb; 9(1):398-407. PubMed ID: 34862747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure.
    Ebner N; Jankowska EA; Ponikowski P; Lainscak M; Elsner S; Sliziuk V; Steinbeck L; Kube J; Bekfani T; Scherbakov N; Valentova M; Sandek A; Doehner W; Springer J; Anker SD; von Haehling S
    Int J Cardiol; 2016 Feb; 205():6-12. PubMed ID: 26705670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Iron Isomaltoside on Skeletal Muscle Energetics in Patients With Chronic Heart Failure and Iron Deficiency.
    Charles-Edwards G; Amaral N; Sleigh A; Ayis S; Catibog N; McDonagh T; Monaghan M; Amin-Youssef G; Kemp GJ; Shah AM; Okonko DO
    Circulation; 2019 May; 139(21):2386-2398. PubMed ID: 30776909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.
    Okonko DO; Grzeslo A; Witkowski T; Mandal AK; Slater RM; Roughton M; Foldes G; Thum T; Majda J; Banasiak W; Missouris CG; Poole-Wilson PA; Anker SD; Ponikowski P
    J Am Coll Cardiol; 2008 Jan; 51(2):103-12. PubMed ID: 18191732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia?
    Kalantar-Zadeh K; Streja E; Miller JE; Nissenson AR
    Adv Chronic Kidney Dis; 2009 Mar; 16(2):143-51. PubMed ID: 19233073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iron deficiency and short-term adverse events in patients with decompensated heart failure.
    Palau P; Llàcer P; Domínguez E; Tormo JP; Zakarne R; Mollar A; Martínez A; Miñana G; Santas E; Almenar L; Fácila L; De La Espriella R; Núñez E; Manzano L; Bayés-Genís A; Núñez J
    Clin Res Cardiol; 2021 Aug; 110(8):1292-1298. PubMed ID: 33721056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and Efficacy of Intravenous Ferric Derisomaltose Compared to Iron Sucrose for Iron Deficiency Anemia in Patients with Chronic Kidney Disease With and Without Heart Failure.
    Ambrosy AP; von Haehling S; Kalra PR; Court E; Bhandari S; McDonagh T; Cleland JGF
    Am J Cardiol; 2021 Aug; 152():138-145. PubMed ID: 34162484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment.
    Kulnigg S; Teischinger L; Dejaco C; Waldhör T; Gasche C
    Am J Gastroenterol; 2009 Jun; 104(6):1460-7. PubMed ID: 19491860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.